GO
Loading...

Bribery

More

  • *China sales slump 61 percent as doctors shun GSK products. LONDON, Oct 23- GlaxoSmithKline's drug sales in China slumped 61 percent in the third quarter, hit by a bribery scandal that has damaged its ability to market products in the country and pushed some sales into the hands of rivals.

  • LONDON, Oct 23- GlaxoSmithKline's drug sales in China tumbled 61 percent in the third quarter, hit by a bribery scandal that has damaged its ability to market medicines in the country.

  • Oct 22- Diebold Inc, the largest U.S. provider of automated teller machines, will pay roughly $48.1 million to settle U.S. criminal and civil charges that it bribed bank officials in China and Indonesia and paid bribes in Russia to win business.

  • NEW YORK, Oct 21- A U.S. judge has thrown out a lawsuit accusing Germany's Siemens AG of funneling kickbacks to Chinese and North Korean hospital officials, narrowing the ability of plaintiffs to use U.S. courts to sue over conduct outside the country.

  • Qatar World Cup bribery claims examined     Wednesday, 9 Oct 2013 | 4:40 AM ET

    Mel Goldberg, senior partner at Mel Goldberg Law, discusses FIFA's investigation on corruption and bribery claims regarding Qatar's successful bid to host the World Cup in 2022.

  • Authorities are investigating British drugmaker GlaxoSmithKline for violations of US anti-bribery laws in China after Chinese government officials accused the company of bribing doctors.

  • Rogue detectives’ client list to be published Wednesday, 4 Sep 2013 | 10:24 AM ET

    The U.K.'s Serious Organised Crime Agency (Soca) has been ordered to make public a list of over 100 companies and individuals who hired corrupt private detectives. A government committee warned Soca that if it did publish the list by Monday, it would be forced to do so instead.

  • JPMorgan's bribery probe involves 200 Asia hires Thursday, 29 Aug 2013 | 6:52 PM ET

    An internal exam of JPMorgan's hiring practices in Asia is looking at the employment of about 200 people for possible instances of illegal nepotism, a source said.

  • Wal-Mart's CEO Mike Duke spoke to CNBC's Maria Bartiromo about the financial impact of the Mexican bribery allegations and says he "will take the appropriate actions; doing the right thing is a part of working at Wal-Mart."

  • China's 'trial of the century' underway     Thursday, 22 Aug 2013 | 6:12 AM ET

    Disgraced Chinese politician Bo Xilai faces charges of bribery, corruption and abuse of power in a move billed by the government as a fight against corruption, reports CNBC's Eunice Yoon.

  • Does JPM have a target on its back?     Monday, 19 Aug 2013 | 4:20 PM ET

    Federal authorities are investigating JPMorgan's hiring of children of influential Chinese officials to help the bank win lucrative business deals. CNBC's Kayla Tausche has the details. And Andrew Stoltmann of Stoltmann Law Offices; and Thomas Curran, Peckar & Abramson, join to discuss the China bribery probe.

  • Glaxo's China woes may extend to its drug research Tuesday, 23 Jul 2013 | 6:31 AM ET

    Glaxo's problems may go beyond the sales practices that are currently at the center of a bribery and corruption scandal in China. They may extend to its Shanghai research and development center.

  • 'Bribe is always a bribe' in GSK allegations     Monday, 22 Jul 2013 | 11:35 AM ET

    Jonathan Russell, senior associate at Alaco, questions if GSK's action against bribery is being seen on the ground.

  • GlaxoSmithKline expected to talk about China probe Sunday, 21 Jul 2013 | 4:17 PM ET
    GlaxoSmithKline Shanghai headquarters

    GlaxoSmithKline CEO Andrew Witty will detail this week what action the drugmaker is taking in response to allegations of bribery against it in China, sources said.

  • China detained and questioned an executive of GlaxoSmithKline, amid an ongoing bribery investigation, reports CNBC's Eunice Yoon.

  • Is China 'unfairly targeting' multinationals?     Wednesday, 17 Jul 2013 | 4:20 AM ET

    Willy Lam, professor at the Chinese University of Hong Kong, says the GSK corruption claim in China appears to be part of a large well-orchestrated campaign against multinationals

  • Wal-Mart Sweetens Board Pay for Bribery Probe Work Tuesday, 23 Apr 2013 | 11:18 AM ET

    Wal-Mart Stores said that members of its board's audit committee were paid more due to extra work they had to take on to handle an ongoing investigation into alleged bribery.

  • Insider Trading & Bribery     Monday, 22 Apr 2013 | 7:25 PM ET

    The SEC charged Mark Begelman with insider trading, reports CNBC's Eamon Javers.

  • The Sands Corp. sign in Las Vegas, Nevada.

    Las Vegas Sands said it "likely" violated the federal Foreign Corrupt Practices Act, which outlaws the bribery of foreign officials, according to a Securities and Exchange Commission filing on Friday.

  • Silvio Berlusconi

    Former Italian Prime Minister Silvio Berlusconi is under investigation on suspicion of bribing a senator to change sides in parliament, deepening the legal troubles of one of the key players in the country's post-election deadlock.

Most Popular Video

Wednesday, 16 Apr 2014 | 9:04 AM ET

The "Squawk on the Street" news team break down Bank of America's Q1 earnings loss thanks largely to legal expenses related to the financial crisis.

Wednesday, 16 Apr 2014 | 4:40 AM ET

Mary travels to Valparaiso, Indiana, where she profiles a miner who grosses hundreds of thousands a year from bitcoin. Then she heads to Austin to profile of a company called CloudHashing that mines bitcoin for wealthy investors, and is positioning itself to capitalize on the massive exchange fees it hopes to collect in the future.

Wednesday, 16 Apr 2014 | 9:08 AM ET

CNBC's Jim Cramer has a bold message for portfolio managers looking for rapid growth: the massive online retailer Alibaba looks like the growth stock to beat all others.